NeuraCell

NeuraCell is a pioneering clinic specializing in the development and application of human brain organoid models, dedicated to advancing the field of neuroscience research and drug discovery. By leveraging innovative technologies, it creates robust induced pluripotent stem cell (iPSC)-derived neural models that replicate human brain development and disease-specific characteristics. These organoids serve as essential tools for researchers exploring neurodegenerative diseases such as Alzheimer’s disease and frontotemporal dementia, offering a human-relevant alternative to traditional animal models. With a commitment to translating neuroscience innovation from lab to clinic, NeuraCell ensures that its platforms are designed to facilitate therapeutic development and personalized medicine. The clinic boasts a wide array of services, including the production of brain organoids at various stages of maturity—ranging from 2 to 6 months—as well as region-specific models such as cortical forebrain and midbrain organoids. These offerings are optimized for disease modeling, target validation, and drug screening. NeuraCell distinguishes itself by providing access to over 100 well-characterized human iPSC lines, allowing for comprehensive biological comparisons through matched CRISPR-corrected control lines. This meticulous approach enhances scientific rigor and supports publication-ready data, ensuring that researchers can effectively utilize these organoids for molecular, functional, and analytical studies. For specialized needs, NeuraCell also offers custom organoid production using client-supplied iPSC lines, making it a versatile partner in the realm of advanced neuroscience research.